SEP 16, 2016 6:26 AM PDT

TSRI Study Suggests Disordered Protein 'Shape Shifts' to Avoid Crowding

How does a cell's crowded environment impact protein behavior? Scientists work to find out.

LA JOLLA, CA – September 16, 2016 – Scientists at The Scripps Research Institute (TSRI) have brought physics and biology together to further understand how cells’ crowded surfaces induce complex protein behavior.

Their findings suggest that a disordered protein, called alpha-synuclein, partially escapes from the cell membrane when it runs out of space.
 
The Scripps Research Institute's Ashok Deniz, Mahdi Muhammad Moosa and Priya Banerjee (left to right) were authors of the new study, which was designated as a "hot paper" by Angewandte Chemie.

“This study provides new insight into the complex structural physics of three-component protein interactions in biology,” said TSRI Associate Professor Ashok Deniz, who led the new study, which was designated as a “hot paper” by the journal Angewandte Chemie.
 

A Crowded Neighborhood


Cells are crowded places, and many biophysicists have studied the effects of such crowding on the structural features of biological molecules, such as proteins. These studies tend to be done in three dimensions, with proteins suspended in a dilute solution and crowded from all sides. The new research brought scientists closer to understanding how crowding on the two-dimensional surface of a cell membrane can influence protein biophysics and function.

“This issue is particularly important given that interactions of some disordered proteins with membranes are critical elements of cellular function and health,” said Deniz.

The team focused on alpha-synuclein because it is an important example of an “intrinsically disordered protein” (IDP), which means it has relatively little structure on its own. Like several other IDPs, it can change its shape depending on interactions with nearby partners. The flexibility of IDPs makes it hard for scientists to capture clear images of them in action. Alpha-synuclein has also been linked to Parkinson’s disease, making it an interesting target for understanding the roles of IDPs in disease.

In the new study, the scientists investigated how alpha-synuclein behaves when the membrane is crowded by a second protein, called Hsp27. By adding this third component to the alpha-synuclein-membrane scene, the scientists came closer to seeing what really happens in a complex cell membrane environment, where real estate is naturally limited.

The researchers found a surprising change in the alpha-synuclein shape when it gets crowded by Hsp27. “The protein is staying partially bound, but our data suggest that part of it is flipping off the surface,” said Deniz.

The scientists said the work combined experiments, observations and simulations, which together pointed toward an explanation of the findings in terms of relatively simple physics.
 

Finding New Partners


The scientists think the section that detaches from the surface might work as an “arm” for waving down new potential partners.

“The fragment of alpha-synuclein can potentially interact with other binding partners, which could initiate further function,” said TSRI Graduate Student Mahdi Muhammad Moosa, who served as first author of the study with TSRI Research Associate Priya R. Banerjee.

The scientists added that other intrinsically disordered proteins may have similar reactions to crowding on membranes by proteins other than Hsp27. “We think the basic features of this model, in principle, could be applied to any intrinsically disordered protein that is bound to the cell membrane,” said Banerjee.

The researchers said the next step in this research will be to study how cell membrane composition and other modifications might alter how crowded membranes modulate the shape and cellular function of intrinsically disordered proteins.

The study, “Two-dimensional crowding uncovers a hidden conformation of α-synuclein,” was supported by the National Institutes of Health’s National Institute of General Medical Sciences (grant RO1 GM066833) and a postdoctoral fellowship from the American Heart Association (grant 15POST22520013).

This article was originally published on scripps.edu.
About the Author
  • The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 2,700 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists-including two Nobel laureates-work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu.
You May Also Like
AUG 10, 2021
Immunology
An Immune Molecule Helps Create 'Good' Fat
AUG 10, 2021
An Immune Molecule Helps Create 'Good' Fat
Not all fat is ‘bad’—there’s white fat that builds up when excess calories are consumed. But, th ...
AUG 13, 2021
Cancer
Ultrasound Triggers Immunotherapy to Destroy Tumors
AUG 13, 2021
Ultrasound Triggers Immunotherapy to Destroy Tumors
An immunotherapy engineered to be triggered by ultrasound beams significantly slows the growth of cancerous tumors in mi ...
AUG 17, 2021
Neuroscience
When Do I Know I'm Me? Researchers Pinpoint Consciousness Patterns
AUG 17, 2021
When Do I Know I'm Me? Researchers Pinpoint Consciousness Patterns
Anti-correlated neurobiological shifts exist between two brain networks involved in consciousness, the "default mode net ...
AUG 26, 2021
Cell & Molecular Biology
Viral Infection Can Have a Lasting Impact on Cells
AUG 26, 2021
Viral Infection Can Have a Lasting Impact on Cells
When a virus infects a cell, it usually takes over the cell's machinery to start churning out viral particles, which are ...
AUG 26, 2021
Coronavirus
Researchers View COVID-19 Progression in a Live Animal Model
AUG 26, 2021
Researchers View COVID-19 Progression in a Live Animal Model
Scientists have used a mouse model to visualize the progression of a SARS-CoV-2 infection as it led to sometimes fatal c ...
SEP 07, 2021
Immunology
Designer Cells for Treating Arthritis Are Activated by Inflammation
SEP 07, 2021
Designer Cells for Treating Arthritis Are Activated by Inflammation
Scientists have developed a new cell therapy for arthritis that becomes activated in the presence of inflammation. When ...
Loading Comments...